Semaglutide to help restart periods in PCOS
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This Phase 3 study tests whether semaglutide can help people with polycystic ovary syndrome (PCOS) start ovulating and having more regular periods. You may join with or without metformin, and contraception rules are important because the medicine must not be used during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are assigned female and are between ages 12 and 35
- You have PCOS with infrequent or absent periods (or no periods after starting menstruation) and blood or physical signs of high androgen levels
- You have low activity (less than 2 hours per week of moderate exercise)
- Your weight fits the study ranges for your age, and your weight has stayed within about 5 kg for the last 3 months
- You can use reliable non-hormonal birth control during the study (like a copper IUD) and avoid pregnancy
- You cannot have certain health problems or medicines that affect insulin, thyroid, or the stomach/intestines (details below)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a weekly injection called semaglutide can help women with PCOS and obesity lose weight and improve their health. It is for women who do not have other serious medical conditions.
This trial tests if a medicine called a GLP-1 agonist (like semaglutide) can help with hormone and ovulation problems in adolescent girls with PCOS and obesity. It aims to improve irregular periods and other PCOS symptoms.
This trial tests if liraglutide, a weight-loss medication, can help obese women with PCOS who have a frozen embryo achieve pregnancy. It aims to improve fertility outcomes by aiding weight loss before embryo transfer.
This study tests whether semaglutide (a weight-loss medication) works differently in people with varying degrees of insulin resistance (how well your body uses sugar). If you are obese without diabetes, you may be able to join.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This trial tests whether semaglutide, a medication used for weight management, can improve the quality of embryos in women who are overweight or have obesity and are doing IVF. It aims to see if taking semaglutide before the IVF process helps make healthier embryos that can be frozen for later use.
Hear when a new PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.